论文部分内容阅读
目的:对缬沙坦联合硝苯地平控释片治疗老年性高血压的治疗效果进行对比和比较。方法:选取自2014年7月至2015年6月间来我院就诊的50例老年性高血压患者为主要研究对象。将其随机分为观察组和对照组,每组各25例。对照组患者采用单一降压药物硝苯地平控释片进行治疗,观察组服用硝苯地平控释片同时联合缬沙坦药物给予治疗。对两组患者的治疗效果进行比较。结果:两组患者在治疗前,SBP、DBP以及HR等指标均无明显性差异,经过治疗后,均得到改善,且观察组患者的改善情况要优于对照组;而且观察组患者治疗的总有效率为92.0%,远远高于对照组的76.0%。两组之间存在明显差异P<0.05,研究结果存在统计学意义。结论:缬沙坦联合硝苯地平控释片药物对老年性高血压进行治疗,临床治疗效果显著,具有较高的应用价值,值得在临床医学中进行大范围推广和应用。
OBJECTIVE: To compare and compare the therapeutic effect of valsartan and nifedipine GITS in the treatment of senile hypertension. Methods: Fifty elderly patients with hypertension who were admitted to our hospital from July 2014 to June 2015 were selected as the main study subjects. They were randomly divided into observation group and control group, 25 cases in each group. Control group patients with a single antihypertensive drug nifedipine controlled release tablets for treatment, the observation group taking nifedipine controlled release tablets combined with valsartan drug treatment. The treatment effect of two groups of patients were compared. Results: Before treatment, there was no significant difference between the two groups in the indexes of SBP, DBP and HR, and after treatment, the improvement was observed, and the improvement in the observation group was better than that in the control group; and the treatment group The effective rate was 92.0%, much higher than 76.0% of the control group. There was a significant difference between the two groups P <0.05, the results of the study there is a statistically significant. Conclusion: Valsartan combined with nifedipine controlled-release tablets in the treatment of senile hypertension, the clinical treatment effect is significant, has a high value, it is worth in the clinical medicine for a wide range of promotion and application.